European therapeutic trials in ANCA-associated systemic vasculitis: disease scoring, consensus regimens and proposed clinical trials. European Community Study Group on Clinical Trials in Systemic Vasculitis ECSYSVASTRIAL.
出版信息
Clin Exp Immunol. 1995 Jul;101 Suppl 1(Suppl 1):29-34. doi: 10.1111/j.1365-2249.1995.tb06161.x.
Abstract
摘要
相似文献
1
European therapeutic trials in ANCA-associated systemic vasculitis: disease scoring, consensus regimens and proposed clinical trials. European Community Study Group on Clinical Trials in Systemic Vasculitis ECSYSVASTRIAL.欧洲抗中性粒细胞胞浆抗体相关系统性血管炎治疗试验：疾病评分、共识方案及拟进行的临床试验。欧洲共同体系统性血管炎临床试验研究组（ECSYSVASTRIAL）
Clin Exp Immunol. 1995 Jul;101 Suppl 1(Suppl 1):29-34. doi: 10.1111/j.1365-2249.1995.tb06161.x.
2
[ANCA vasculitis].[抗中性粒细胞胞浆抗体血管炎]
Nefrologia. 2003;23(2):103-6.
3
Association of ANCA-positive vasculitis with thyroid disease.抗中性粒细胞胞浆抗体（ANCA）阳性血管炎与甲状腺疾病的关联。
Nephrol Dial Transplant. 2008 Jun;23(6):2107; author reply 2107-8. doi: 10.1093/ndt/gfn030. Epub 2008 Mar 6.
4
Current treatment strategies in ANCA-positive renal vasculitis-lessons from European randomized trials.
Nephrol Dial Transplant. 2003 Jul;18 Suppl 5:v2-4. doi: 10.1093/ndt/gfg1032.
5
ANCA anti-idiotype antibodies and the treatment of systemic vasculitis with intravenous immunoglobulin.抗中性粒细胞胞浆抗体（ANCA）抗独特型抗体与静脉注射免疫球蛋白治疗系统性血管炎
J Autoimmun. 1993 Apr;6(2):207-19. doi: 10.1006/jaut.1993.1018.
6
Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group.抗中性粒细胞胞浆自身抗体相关系统性血管炎的治疗：欧洲共同体系统性血管炎临床试验研究组的倡议
Mayo Clin Proc. 1997 Aug;72(8):737-47. doi: 10.1016/S0025-6196(11)63594-5.
7
[Diagnostic and pathogenic significance of antineutrophil cytoplasmic antibodies in vasculitides].[抗中性粒细胞胞浆抗体在血管炎中的诊断及致病意义]
Bratisl Lek Listy. 1995 Oct;96(10):528-33.
8
9
Systemic vasculitis: still a challenging disease.系统性血管炎：仍然是一种具有挑战性的疾病。
Am J Kidney Dis. 2005 Aug;46(2):173-85. doi: 10.1053/j.ajkd.2005.04.018.
10
Pathogenesis and treatment of ANCA-associated systemic vasculitis.抗中性粒细胞胞浆抗体相关性系统性血管炎的发病机制与治疗
J R Soc Med. 1999 Sep;92(9):456-61. doi: 10.1177/014107689909200906.
引用本文的文献
1
ANCA-associated vasculitis and the impact of diffuse alveolar hemorrhage in elderly patients: a retrospective cohort study.抗中性粒细胞胞浆抗体相关性血管炎及弥漫性肺泡出血对老年患者的影响：一项回顾性队列研究
Rheumatol Int. 2025 Mar 3;45(3):68. doi: 10.1007/s00296-025-05812-8.
2
Cluster analysis of patients with granulomatosis with polyangiitis (GPA) based on clinical presentation symptoms: a UK population-based cohort study.基于临床表现症状对肉芽肿性多血管炎（GPA）患者进行聚类分析：一项英国基于人群的队列研究。
Arthritis Res Ther. 2022 Aug 19;24(1):201. doi: 10.1186/s13075-022-02885-9.
3
Cyclophosphamide induction dose and outcomes in ANCA-associated vasculitis with renal involvement: A comparative cohort study.环磷酰胺诱导剂量与伴有肾损害的抗中性粒细胞胞浆抗体相关性血管炎的结局：一项比较队列研究。
Medicine (Baltimore). 2021 Jul 23;100(29):e26733. doi: 10.1097/MD.0000000000026733.
4
Glucocorticoid maintenance therapy and severe infectious complications in ANCA-associated vasculitis: a retrospective analysis.糖皮质激素维持治疗与抗中性粒细胞胞质抗体相关性血管炎的严重感染并发症：一项回顾性分析。
Rheumatol Int. 2021 Feb;41(2):431-438. doi: 10.1007/s00296-020-04752-9. Epub 2020 Nov 22.
5
Clinical practice variation and need for pediatric-specific treatment guidelines among rheumatologists caring for children with ANCA-associated vasculitis: an international clinician survey.照顾抗中性粒细胞胞浆抗体相关性血管炎患儿的风湿病学家之间的临床实践差异及对儿科特异性治疗指南的需求：一项国际临床医生调查
Pediatr Rheumatol Online J. 2017 Aug 7;15(1):61. doi: 10.1186/s12969-017-0191-z.
6
Vasculitis for the internist: focus on ANCA-associated vasculitis.内科医生眼中的血管炎：聚焦抗中性粒细胞胞浆抗体相关性血管炎
Intern Emerg Med. 2017 Aug;12(5):577-585. doi: 10.1007/s11739-017-1683-z. Epub 2017 Jun 16.
7
Therapy and prognosis of ANCA-associated vasculitis from the clinical nephrologist's perspective.从临床肾脏病学家角度看抗中性粒细胞胞浆抗体相关性血管炎的治疗与预后
Int Urol Nephrol. 2017 Jan;49(1):91-102. doi: 10.1007/s11255-016-1419-4. Epub 2016 Sep 26.
8
Changing patterns of clinical severity and risk of mortality in granulomatosis with polyangiitis over four decades: the Russian experience.
Rheumatol Int. 2015 May;35(5):891-8. doi: 10.1007/s00296-014-3154-4. Epub 2014 Oct 26.
9
Recurrent gastrointestinal bleeding with ANCA associated glomerulonephritis successfully treated by transarterial embolization.抗中性粒细胞胞质抗体相关性血管炎肾损害合并反复消化道出血行选择性动脉栓塞治疗疗效好。
Pak J Med Sci. 2013 Nov;29(6):1465-7. doi: 10.12669/pjms.296.3669.
10
Conditions in subjects with rheumatic diseases: pulmonary manifestations of vasculitides.风湿病患者的情况：血管炎的肺部表现。
Arthritis Res Ther. 2011 Jun 30;13(3):224. doi: 10.1186/ar3307.
本文引用的文献
1
Cellular immune responses and pathogenesis in c-ANCA positive vasculitides.抗中性粒细胞胞浆抗体（c-ANCA）阳性血管炎中的细胞免疫反应与发病机制
J Autoimmun. 1993 Apr;6(2):227-36. doi: 10.1006/jaut.1993.1020.
2
The value of indirect immunofluorescence and solid phase techniques for ANCA detection. A report on the first phase of an international cooperative study on the standardization of ANCA assays. EEC/BCR Group for ANCA Assay Standardization.间接免疫荧光法和固相技术在抗中性粒细胞胞浆抗体（ANCA）检测中的价值。抗中性粒细胞胞浆抗体检测标准化国际合作研究第一阶段报告。欧洲经济共同体/生物技术协调行动组织抗中性粒细胞胞浆抗体检测标准化小组
J Immunol Methods. 1993 Feb 26;159(1-2):1-16. doi: 10.1016/0022-1759(93)90136-u.
3
Effectiveness of cyclophosphamide pulse treatment in Wegener's granulomatosis.环磷酰胺脉冲治疗在韦格纳肉芽肿病中的疗效
Adv Exp Med Biol. 1993;336:483-6. doi: 10.1007/978-1-4757-9182-2_87.
4
Pooled intravenous immunoglobulin in the management of systemic vasculitis.静脉注射免疫球蛋白在系统性血管炎治疗中的应用
Adv Exp Med Biol. 1993;336:469-72. doi: 10.1007/978-1-4757-9182-2_84.
5
Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis.金黄色葡萄球菌慢性鼻腔携带与韦格纳肉芽肿较高复发率的关联。
Ann Intern Med. 1994 Jan 1;120(1):12-7. doi: 10.7326/0003-4819-120-1-199401010-00003.
6
Nomenclature of systemic vasculitides. Proposal of an international consensus conference.系统性血管炎的命名法。国际共识会议提案。
Arthritis Rheum. 1994 Feb;37(2):187-92. doi: 10.1002/art.1780370206.
7
Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy.单克隆抗体疗法使难治性系统性血管炎长期缓解。
Lancet. 1993 Jun 26;341(8861):1620-2. doi: 10.1016/0140-6736(93)90759-a.
8
Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener's granulomatosis.疾病表现和抗中性粒细胞胞浆抗体滴度对韦格纳肉芽肿患者环磷酰胺冲击治疗反应的影响。
Arthritis Rheum. 1994 Jun;37(6):919-24. doi: 10.1002/art.1780370622.
9
Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.系统性坏死性血管炎中的伯明翰血管炎活动评分（BVAS）
QJM. 1994 Nov;87(11):671-8.
10
Classification and epidemiology of systemic vasculitis.
Br J Rheumatol. 1994 Oct;33(10):897-9. doi: 10.1093/rheumatology/33.10.897.
Zotero 插件